Issue 60, 2023

A dual covalent binder for labelling and inhibiting serine and metallo-carbapenemases

Abstract

The continuous emergence of multi-drug resistant pathogens co-expressing serine and metallo-carbapenemases seriously threatens the efficacy of carbapenem. Here, we report the first SeCN-derived dual inhibitor of serine and metallo-carbapenemases with IC50 values ranging from 0.0038 to 1.27 μg mL−1. The inhibitor was shown to form covalent bonds with Cys221 of NDM-1 and Ser70 of KPC-2, respectively, achieving selective labelling and cross-class inhibition for carbapenemases. Our results provide a potential strategy to develop clinically useful dual inhibitors targeting serine and metallo-carbapenemases to combat superbugs.

Graphical abstract: A dual covalent binder for labelling and inhibiting serine and metallo-carbapenemases

Supplementary files

Article information

Article type
Communication
Submitted
19 May 2023
Accepted
29 Jun 2023
First published
29 Jun 2023

Chem. Commun., 2023,59, 9227-9230

A dual covalent binder for labelling and inhibiting serine and metallo-carbapenemases

C. Chen, Y. Xu, P. Oelschlaeger, J. Brem, L. Liu, D. Wang, H. Sun and K. Yang, Chem. Commun., 2023, 59, 9227 DOI: 10.1039/D3CC02373G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements